Selected Milestones in Antiviral Drug Development.
Viruses
; 16(2)2024 01 23.
Article
en En
| MEDLINE
| ID: mdl-38399945
ABSTRACT
This review article will describe the (wide) variety of approaches that I envisaged to develop a specific therapy for viral infections (i) interferon and its inducers, (ii) HSV, VZV and CMV inhibitors, (iii) NRTIs (nucleoside reverse transcriptase inhibitors), NtRTIs (nucleotide reverse transcriptase inhibitors) and NNRTIs (non-nucleoside reverse transcriptase inhibitors) as HIV inhibitors, (iv) NtRTIs as HBV inhibitors, and finally, (v) the transition of an HIV inhibitor to a stem cell mobilizer, as exemplified by AMD-3100 (Mozobil®).
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Virosis
/
Infecciones por VIH
/
Fármacos Anti-VIH
Límite:
Humans
Idioma:
En
Revista:
Viruses
Año:
2024
Tipo del documento:
Article
País de afiliación:
Bélgica